Home Factor company Koios Provides MCTO Status Update

Koios Provides MCTO Status Update

0

DENVER, Oct. 13, 2022 (GLOBE NEWSWIRE) — Koios Beverage Corp. (CSE: FIT; OTC: FITSF) (the “Company” or “Kioos”) provides this update on the status of a management cease trade order granted on September 29, 2022 (the “MCTO”) by the British Columbia Securities Commission under the National Policy 12-203 – Management Cease Trade Order (“NP 12-203”). On September 29, 2022, the Company announced that, for the reasons disclosed in the press release, there would be a delay in filing its financial statements and related MD&A for the fiscal year ended May 31, 2022 (the “Annual Report Filings”) beyond the time period required by applicable Canadian securities laws (the “Notice of Default”).

The Company reports that the audit is progressing and will provide a further update on the timing of its annual filings on or about October 28, 2022. The Company is also progressing with the completion of its interim financial statements and MD&A. accompanies for the first quarter ended August 31, 2022, and will provide a further update no later than October 28, 2022. Further updates on the schedule will be provided by the Company as needed.

During the MCTO, the general investing public will continue to be able to trade the Company’s publicly traded common stock. However, the CEO and CFO of the Company will not be able to trade in the common shares of the Company.

Except as disclosed in this press release, there are no material changes to the information contained in the Default Announcement. The Company confirms that it intends to comply with the provisions of IG 12-203 and that it will continue to issue default status reports every two weeks as long as it remains in default of the annual filing requirement.

On behalf of the Company’s Board of Directors,

KOIOS BEVERAGE CORP.

“Chris Miller”

Chris Miller, CEO, Interim CFO and Director

For more information, please contact:

Gina Burrus
844-255-6467
[email protected]

THE CANADIAN SECURITY EXCHANGE (CSE) HAS NOT REVIEWED AND ACCEPTS NO RESPONSIBILITY FOR THE ACCURACY OR SUITABILITY OF THIS RELEASE.

About Koios Beverage Corp.

The Company is an emerging functional beverage company that has a distribution network of over 4,400 outlets in the United States to sell its products. Koios has relationships with some of the largest and most reputable distributors in the United States, including Europa Sports, Muscle Foods USA, KeHE and Wishing-U-Well. Koios uses a proprietary blend of nootropics and natural organic compounds to enhance human productivity without the use of harmful chemicals or stimulants. Koios products have been shown to improve focus, mental capacity, memory retention, cognitive function, alertness, brain capacity and create all-day mental clarity. Its ingredients are specifically designed to target brain function by increasing blood flow, oxygen levels, and neural connections in the brain.

Koios produces one of the only beverages in the world infused with MCT oil. MCT Oil is derived from coconuts and has been shown to help the body burn fat more efficiently, create sustained energy from a natural food source, produce ketones in the brain, enabling better brain function and clarity, supporting the production of healthy hormones and improving immunity. . For more information, please visit our website: https://www.koiosbeveragecorp.com.

Forward-looking statements

This press release contains “forward-looking information” within the meaning of applicable Canadian securities laws. Often, but not always, forward-looking information and information can be identified by the use of words such as “anticipates”, “expects” or “does not expect”, “is expected”, “estimates”. , “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of these words and expressions or states that certain actions, events or results “may”, “could”, “would”, “could” or “will” be taken, occur or be carried out. Forward-looking information in this press release includes statements regarding the Company’s intention to issue the Bonus Warrants and the expiration of the hold periods applicable to the securities issued pursuant to the private placement. Forward-looking information reflects management’s current expectations based on information currently available and is subject to a number of risks and uncertainties that could cause actual results to differ materially from those discussed in the forward-looking information. Although the Company believes that the assumptions and factors used in the preparation of the forward-looking information are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur within the time periods stated or not. at all. Factors that could cause actual results or events to differ materially from current expectations include: (i) adverse market conditions; (ii) changes in the growth and size of functional beverage markets; and (iii) other factors beyond the Company’s control. The Company operates in a rapidly changing environment. New risk factors emerge from time to time, and it is impossible for the management of the Company to predict all risk factors, nor can the Company assess the impact of all factors on the business of the Company. Company or the extent to which any factor, or combination of factors, could cause actual results to differ from those contained in the forward-looking information. The forward-looking information included in this press release is made as of the date of this press release, and the Company expressly disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise. , except as required by applicable law.

The statements in this press release have not been evaluated by Health Canada or the United States Food and Drug Administration. As each individual is different, the benefits, if any, of taking the Company’s products will vary from person to person. No claim or warranty can be made as to the effects of the Company’s products on the health and well-being of any individual. The Company’s products are not intended to diagnose, treat, cure or prevent any disease.

This press release may contain brand names of third-party entities (or their respective offerings with brand names) generally in reference to (i) Koios’ relationship with such third-party entities as referenced in this release and/or ( (ii) the customer/supplier/service provider parties whose relationship with Koios is/are mentioned in this release. All rights in these marks are reserved by their respective owners or licensees.

Contact information:
Gina Burrus
vice-president
[email protected]

This content was posted through the press release distribution service on Newswire.com.